DNA methylation differences in human p14.5 gene promoter region in normal and proliferating cells

Development Growth and Differentiation

Volumn 47, Issue 7, 2005, Pages 493-499

  Pozdniakovaite, Natalija ^a   Popendikyte, Violeta ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

DNA methylation; Human p14.5; Promoter; PSP

Indexed keywords

CYTOSINE; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA FLANKING REGION; DNA METHYLATION; GENE EXPRESSION; GENE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MONOCYTE; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF;

CELL DIFFERENTIATION; CELL PROLIFERATION; DNA METHYLATION; GENE EXPRESSION REGULATION; HEAT-SHOCK PROTEINS; HELA CELLS; HUMANS; JURKAT CELLS; K562 CELLS; MACROPHAGES; MITOCHONDRIAL PROTEINS; RESPONSE ELEMENTS; RIBONUCLEASES;

EID: 27744603580     PISSN: 00121592     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-169X.2005.00824.x     Document Type: Article

References (23)

1. Ballestar, E. & Esteller, M. 2005. The epigenetic breakdown of cancer cells: from DNA methylation to histone modifications. Prog. Mol Subcell. Biol. 38, 169-181.
2. Bartorelli, A., Biancardi, C., Cavalca, V. et al. 1996a. Purification and partial characterization of proteins present in a perchloric acid extracts of goat liver cross-reacting with human tumor. J. Tumor Marker Oncol. 11, 57-61.
3. Bartorelli, A., Bussolati, B., Millesimo, M., Gugliotta, P. & Bussolati, G. 1996b. Antibody-dependent cytotoxic activity on human cancer cells expressing UK114 tumor membrane antigen. Int. J. Oncol. 8, 543-548.
4. Bird, A. P. & Wolffe, A. P. 1999. Methylation-induced repression - belts, braces, and chromatin. Cell 99, 451-454.
5. Birnboim, H. C. & Doly, J. 1979. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucl. Acids Res. 7, 1513.
6. Brown, R. & Strathdee, G. 2002. Epigenomics and epigenetic therapy of cancer. Trends Mol. Med. 8, S43-S48.
7. Bussolati, G., Guena, M., Bussolati, B., Millesimo, M., Botta, M. & Bartorelli, A. 1997. Cytolytic and tumor inhibitory antibodies against UK114 protein in the sera of cancer patients. Int. J. Oncol. 10, 779-798.
8. Kaneki, K., Kanouchi, H., Matsumoto, M., Kawasaki, Y., Akuzawa, M. & Oka, T. 2003. Down regulation of a novel protein, PSP, in rat hepatoma cdRLh 84-beared tumor. J. Vet Med. Sci. 65, 781-785.
9. Kanouchi, H., Tachibana, H., Oka, T. & Yamada, K. 2001. Recombinant expression of perchloric acid-soluble protein reduces cell proliferation. Cell. Mol. Life Sci. 58, 1340-1343.
10. Manjasetty, B. A., Delbruck, H., Pham, D. T. et al. 2004. Crystal structure of Homo sapiens protein hp14.5. Proteins 54, 797-800.
11. Marreiros, A., Dudgeon, K., Dao, V. et al. 2005. KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells. Oncogene 24, 637-649.
12. Melloni, E., Michetti, M., Salamino, F. & Pontremoli, S. 1998. Molecular and functional properties of a calpain activator protein specific for mu-isoforms. J. Biol. Chem. 273, 12827-12831.
13. Ng, H. H., Jeppesen, P. & Bird, A. 2000. Active repression of methylated genes by the chromosomal protein MBD1. Mol. Cell. Biol. 20, 1394-1406.
14. Olek, A., Oswald, J. & Walter, J. 1996. A modified and improved method for bisulphite based cytosine methylation analysis. Nucl. Acids Res. 24, 5064-5066.
15. Panerai, A. E., Sacerdote, P., Bianchi, M. et al. 1999. Chronic administration of UK-114, a multifunctional emerging protein, modulates the Th1/Th2 cytokine pattern and experimental autoimmune diseases. Ann. NY Acad. Sci. 876, 229-235.
16. Pozdniakovaite, N. & Popendikyte, V. 2004. Identification of differentially expressed genes in yeast Saccharomyces cerevisiae cells with inactivated Mmf1p and Hmf1p, members of proteins family YERO57c/YJGF. Dev. Growth Differ. 46, 545-554.
17. Racca, S., Di Carlo, F., Bartorelli, A., Bussolati, B. & Bussolati, G. 1997. Growth inhibition of DMBA-induced rat mammary carcinomas by UK 114. Virchows Arch. 431, 323-328.
18. Razin, A. & Cedar, H. 1991. DNA methylation and gene expression. Microbiol. Rev. 55, 451-458.
19. Richards, E. J. & Elgin, S. C. 2002. Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell 108, 489-500.
20. Rideout, W. M. 3rd, Eggan, K. & Jaenisch, R. 2001. Nuclear cloning and epigenetic reprogramming of the genome. Science 293, 1093-1098.
21. Schmiedeknecht, G., Kerkhoff, C., Orso, E. et al. 1996. Isolation and characterization of a 14.5-kDa trichloroacetic-acid-soluble translational inhibitor protein from human monocytes that is upregulated upon cellular differentiation. Eur. J. Biochem. 242, 339-351.
22. Schmiedeknecht, G., Buchler, C. & Schmitz, G. 1997. A bidirectional promoter connects the p14.5 gene to the gene for RNase P and RNase MRP protein subunit hPOP1. Biochem. Biophys. Res. Commun. 241, 59-67.
23. Schmutte, C. & Jones, P. A. 1998. Involvement of DNA methylation in human carcinogenesis. Biol. Chem. 379, 377-388.